HOME | Research | Media | Careers | Contacts | Products | Search | Publications | Site Map
CSIRO Mathematics, Informatics and Statistics

 

 

Image Analysis
Biotech Imaging Group
Application Areas
 Biotechnology
 Cellular Screening
 Health
 Asset Monitoring
 Exploration
 Other Areas
Skills
 Segmentation
 Feature Extraction
 Statistical Analysis
 Stereo Vision
 Image Motion
 
Projects
Imaging Services
Imaging Products
Track Record
Publications
Patents
Staff

HCA Modules

Translocation Assays

We have developed automated solutions for the translocation assays commonly used in target identication/validation and compound screening in drug discovery.

We have research collaborations in which we have custom developed solutions for Nucleus-Cytoplasm translocation for more difficult primary cells.

Commercial Partners

Our conventional translocation analysis code has been integrated into the HCA cellular imaging systems of:

  • Molecular Devices (formerly Axon Instruments) (http://www.axon.com) are a major biotechnology instrumentation company that CSIRO has worked with in the development of their ImageXpressTM cellular screening system.

If you would like to licence this module for integration into your software platform please see the contact details below.

Custom Solutions

We develop custom solutions for non-standard assays. If you'd like a quote please see the contact details below.

Nucleus-Cytoplasm translocation for commonly used cell lines

A typical cytoplasm channel image

Isotropic "donuts"

Anisotropic "donuts"

A typical cytoplasm channel image with densely packed cells from a common cell line. When well separated, these cells are roughly elliptical in shape and the cytoplasm is symmetrically located around the nucleus.

In widefield microscopy, it is difficult to segment the cytoplasm directly. So cytoplasm measurements are usually taken using a surrogate for the cytoplasm - an isotropic "donut" region around the nucleus.

When cells are densely packed, isotropic donuts will include some background. Our solution allows the use of anisotropic "donuts". This reduces the likelihood that low signal background will bias  the cytoplasm measurement.

Nucleus-Cytoplasm translocation for more difficult primary cells

Densly packed primary cells

Adaptive donuts as new cytoplasm surrogates

A typical cytoplasm channel image with densely packed primary cells. Even when well separated, these cells are not elliptical in shape and nor is the cytoplasm symmetrically located around the nucleus.

We have developed a new cytoplasm surrogate using adaptive donuts. These expand within the cytoplasm differentially to avoid the background. This significantly reduces the false alarm rate from incorrect cytoplasm measurements.

Cytoplasm-vesicle translocation

Negative result of cytoplasm-to-vesicle translocation assay Count of vesicles/dots in the full image Atypical cells with low response can be detected
A typical cytoplasm-to-vesicle translocation assay – a negative result is shown above, a positive result is shown below. Standard solutions just count the vesicles/dots in the full image. So heterogeneous responses cannot be detected. Our solution allocates each vesicle/dot to a single cell. So atypical cells with high or low response can be detected.
Positive result of cytoplasm-to-vesicle translocation assay Count of vesicles/dots in the full image Atypical cells with high response can be detected

For further information, please contact:

Pascal Vallotton
Leader, Biotech Imaging
CSIRO Mathematics, Informatics and Statistics
Locked Bag 17, North Ryde NSW 1670 AUSTRALIA
Phone: +61 (0)2 9325 3208
Fax: +61 (0)2 9325 3200
Email: pascal.vallotton@csiro.au
Leanne Bischof
Biotech Imaging
CSIRO Mathematics, Informatics and Statistics
Locked Bag 17, North Ryde NSW 1670 AUSTRALIA
Phone: +61 (0)2 9325 3206
Fax: +61 (0)2 9325 3200
Email:
leanne.bischof@csiro.au

To top

last updated October 29, 2009 01:07 PM
Ryan.Lagerstrom@csiro.au

© Copyright 2013, CSIRO Australia
Use of this web site and information available from
it is subject to our
Legal Notice and Disclaimer and Privacy Statement